Oxybutynin significantly reduced hot flash frequency and severity compared with placebo among men with prostate cancer ...

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. Researchers have now created an AI diagnostic tool that can help.

Men receiving treatment for prostate cancer often face challenges that extend well beyond the disease itself. A new study led ...

"This technology gives us a powerful tool to detect prostate cancer earlier and more precisely,” said Dr. James Howard.

New study finds microplastics in 90% of prostate cancer tumors, with double the concentration in cancerous tissue compared to ...

Researchers and clinicians from six leading medical centers and academic institutions—including the University of California San Diego—have collaborated to develop a new artificial intelligence model ...

Microplastics were found in 90% of prostate tumors, with 2.5 times higher concentrations than in healthy cells. Reducing plastic exposure may help lower risk.

Richard Attack is sharing his prostate cancer story to help raise awareness ...

Microplastics have now been found inside most prostate cancer tumors — and at strikingly higher levels than in healthy tissue ...

Researchers are evaluating the P-CARE model, which integrates results from a blended genome-exome sequencing assay and family ...

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.

About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.